RICHARD D. HEBERT
**** ***** ***** ***** 408-***-**** (mobile)
**************@*******.***
A senior level position in Operations/General Management in an environment that demands sound leadership and
management abilities, drawing upon a unique and diverse background of operations, quality, regulatory affairs, and
engineering management, creativity and measurable productivity.
Summary:
A results-oriented, hands on executive with experience in the high technology and medical device industries. Employs a
team-based management style that encourages and supports continuous improvement and innovative risk taking. Extensive
experience leading and managing cross-functional teams. General management and P&L experience. A skilled problem
solver with a proven track record in managing crisis and turn-around situations. Extensive growth in progressively
responsible positions in operations, quality and engineering management. Expertise includes:
• •
ISO 9000 Continuous Improvement
• •
ISO 13485 Quality System Remediation
• •
ISO 14971 Engineering
• •
21 CFR Part 820 Quality Assurance
• •
Health Canada Medical Devices Regulation Regulatory Affairs
• •
Medical Device Directive 93/42/EEC Supplier Quality Agreements
• •
Class I, II, and III medical devices Document Control
• •
QSR/cGMP Multi-plant and international experience
• •
CE Marking Design and Change Controls
• •
Yield optimization Gap Analyses
• •
Cycle time reduction Sterile Disposables
• •
Lean Manufacturing 6-Sigma
3 Professional Experience:
QRO Consulting Services 2005- present
Principal & Founder, Consultant
Operations, quality, and regulatory consultation to medical device and medical device related companies. Provides operations,
quality systems and regulatory services to medical device companies for efficiencies improvement, validations, regulatory
submissions, quality system remediation, quality system implementation, and quality audits.
Recent assignments include:
• Providing Manufacturing Operations consultation to a development-stage radio-oncology implant medical device
company to build sufficient quantities of class III devices in support of human clinicals.
• Providing leadership to a leading medical device company under a Warning Letter from FDA to establish adequate
design and process validation methodologies which also significantly improved production efficiencies.
• Preparing a regenerative medicine medical device company whose ISO 13485 certification and CE Mark were in
jeopardy to pass its ISO 13485 audit, thereby preserving its ISO 13485 certification and CE Mark.
• Acting Global Director of Quality for a multi-billion dollar Fortune 500 medical device company and having a key
role in selecting the new Global Director of Quality.
• Preparing for and hosting ISO and supplier audits for medical device companies.
• Leading the effort to obtain CE Marking for various medical device companies.
• Obtaining FDA medical device establishment registration for an IVD manufacturing facility in Eastern Europe.
• Identifying and correcting inadequacies in a leading IVDD medical device company’s quality system.
• Interim Director of Regulatory Affairs & Quality Assurance for a multi-billion dollar Fortune 500 medical device
company, driving manufacturing process validations and efficiencies, preparing for FDA inspection readiness, and
improving change control and risk assessment methodologies.
Richard D. Hebert
Page 2
IntraLuminal Therapeutics 2004 – 2005
1 Vice President, Operations
2 IntraLuminal Therapeutics manufactured and distributed capital equipment and guidewire devices that
utilize optical coherent reflectometry, enabling the interventionalist to cross Chronic Total
Occlusions (CTOs). Responsible for the development and manufacture of a Class II medical
device. Responsibility for Engineering, Manufacturing, and Materials & Purchasing functions.
Through my leadership and utilizing Lean Manufacturing and 6-Sigma methodologies, the
organization improved disposable yields from 55% to 77%, improved 1 st pass capital equipment
burn-in yields from 20% to 95%, reduced material scrap from 61% to 35%, and double capital
equipment and disposable production capacity.
Inadequate sales forced the closure of the company, and its assets were sold.
TRANSURGICAL INC. 2002 – 2003
3 Vice President, Operations
Corporate Officer
Responsibility for Engineering, Manufacturing, Quality, and Materials & Purchasing functions.
Responsible for the development and manufacture of a Class III medical device. Lead program
to utilize High Intensity Focused Ultrasound (HIFU) for the treatment of atrial fibrillation
(AFIB). Spearheaded effort to make necessary design enhancements to transition from
pivotal animal studies to human clinicals. Established manufacturing and built class 100,000
cleanroom. Built a cohesive, multidisciplinary team through participatory management,
collaboration and consensus building. Helped to plan and execute European pilot study.
Transurgical’s CEO, formerly my CEO at EndoSonics, recruited me to remotivate his team.
The pilot human clinical study indicated that the device worked much better with canine
anatomy than with human anatomy, necessitating a complete redesign. Thus, the company had
a greater need for a gifted catheter designer than an operations professional, so I helped to hire
a catheter engineer with the required skill-set prior to leaving Transurgical and returning to
California.
ENDOSONICS CORPORATION 1998- 2002
Vice President, Worldwide Quality Assurance/Regulatory/Clinical Affairs Corporate Officer
Assessed the state of the organization through intensive external/internal auditing. Partnered with Human Resources and the
Employment Training Panel (ETP) and secured $200,000 towards corporate-wide quality training. Passed previously failed ISO
9000 audits in the U.S. and Europe. Responsible for regulatory submissions and quality assurance of Class II and Class III
medical devices. Achieved 510(k) clearance for disposable pullback device, CE marking for Vintage™ line of PTCA catheters,
IDE clearance for Brigade radiation catheter. Engaged governing officials, England and the Czech Republic ISO 9000
Standards, in on-going Best Practice Review.
Jomed, a European medical device company, acquired EndoSonics in September 2000, and as a member of EndoSonics’ senior
staff, my Change of Control agreement took effect. As part of the agreement, I continued providing the company with
consultation on an “as needed” basis.
BIOSURGICAL-BIOINTERVENTIONAL 1997 - 1998
Vice President, Operations and Administration Corporate Officer
Created and implemented standard operating procedures and Quality Manual for QSR, ISO 9000, and OSHA compliance.
Devised the corporate strategy to obtain CE marking in the shortest time and most cost-effective manner. Tracked cash flow and
implemented actual vs. budget reporting for the entire company to monitor burn rate. Planned for limited and high-volume
manufacturing of fibrin sealant and collagen delivery devices for wound closure, given various business scenarios. Built
cleanroom certified to Class 100,000.
In 1998, EndoSonics’ CEO asked that I return to the company as Vice President of
Worldwide Quality Assurance/Regulatory Affairs/Clinical Affairs, to correct issues with
compliance to quality systems and regulatory submissions.
Richard D. Hebert
Page 3
ENDOSONICS CORPORATION 1993-1997
Vice President, Operations and General Manager Corporate Officer
• Started as Director, Quality Assurance, promoted to Vice President, Quality
Assurance, then Vice President, Operations.
• Responsible for the development, manufacture, and quality assurance of Class II
medical devices.
• Successfully turned-around a fully autonomous, high-volume, catheter-based
ultrasound, PTCA catheter, drug delivery catheter, and stent delivery system manufacturing
facility staffed by 118 employees.
• P&L responsibility, growing revenues to from $4,000,000 to $11,000,000 EBITA.
• Led company out of a serious backorder situation.
• Responsible for Manufacturing, Quality Assurance, Materials, Engineering, and
Human Resources.
• Interfaced with Sales & Marketing to establish production forecasts, and with Finance
for cost-of-goods objectives.
• Reduced employee turnover from 30% to 3%.
• Led team towards JIT and TQM goals. Utilizing Lean Manufacturing and 6-Sigma
methodologies, realized greater than 200% increase in gross revenues while improving gross
margins from single digits to greater than 50%, resulting in profitability.
• Re-engineered production lines to minimize scrap and improve yields from 30% to
90%.
• Reduced product cost by 50% while enhancing product designs, lowering costs by an
additional 15%.
As Director of Quality:
• Successfully corrected or rebutted 53 observations of non-compliance on a Form 483
from an FDA audit performed six months prior to joining the company.
• Managed Customer Service, and implemented processes to improve responsiveness.
For the two years prior to leaving the company, I had the role of Vice President of Operations
and General Manager with responsibility for the business unit in the San Francisco Bay Area.
The CEO decided to consolidate the company’s U.S. operations under one roof, in
Sacramento, California, necessitating the shutdown of my facility. I had the option of
remaining with EndoSonics or taking a package, and I opted for the latter.
RESONEX 1991-1993
Manager, Quality Assurance
Responsible for FDA, UL, and TUV compliance. Assured the safety and reliability of MRI systems prior to shipment. Created
Quality Council to involve managers from all departments that had an impact on the quality of products and services. Ensured
GMP compliance.
Education:
Bachelor of Arts Degree in Physics, minor in Mathematics, from San Jose State University, San
Jose, CA.
Associate in Arts Degree from Diablo Valley College, Pleasant Hill, CA.
Successfully completed various Computer Science courses at California State University,
Sacramento, CA.
Professional Organizations:
Member of the American Society for Quality (ASQ).
Member of the Association for the Advancement of Medical Instrumentation (AAMI).
Member of the American National Standards Institute (ANSI).
Member of IEEE Magnetics.